Actinogen Medical Limited
ATGGF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$6,563 | -$8,169 | -$1,488 | -$11,557 |
| Dep. & Amort. | $220 | $203 | $205 | $212 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $930 | $733 | $727 | $580 |
| Change in WC | $3,537 | $0 | -$5,236 | $0 |
| Other Non-Cash | -$7,419 | $8,972 | -$4,668 | $4,273 |
| Operating Cash Flow | -$9,295 | $1,739 | -$10,459 | -$6,491 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$36 | -$2 | -$7 | -$2 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$36 | -$2 | -$7 | -$2 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$29 | $0 | -$42 |
| Stock Issued | $0 | $0 | $8,494 | $9,548 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2,969 | $11,708 | $8,444 | $9,548 |
| Financing Cash Flow | $2,969 | $11,679 | $8,444 | $9,505 |
| Forex Effect | $0 | $0 | $0 | $8,460 |
| Net Chg. in Cash | -$22,866 | $22,866 | -$2,022 | $11,472 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $22,866 | $0 | $11,472 | $8,460 |
| End Cash | $0 | $22,866 | $9,451 | $11,472 |
| Free Cash Flow | -$9,331 | $1,737 | -$10,466 | -$6,493 |